OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves adjusting various parameters, including cell line development, media composition, and bioreactor settings. A key goal is to maximize antibody yield while reducing production costs and